Turtle Creek Wealth Advisors LLC increased its stake in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 5.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 35,095 shares of the company's stock after acquiring an additional 1,861 shares during the quarter. Procter & Gamble makes up about 1.4% of Turtle Creek Wealth Advisors LLC's portfolio, making the stock its 22nd largest position. Turtle Creek Wealth Advisors LLC's holdings in Procter & Gamble were worth $5,884,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. RPg Family Wealth Advisory LLC bought a new stake in Procter & Gamble during the 3rd quarter worth approximately $33,000. New Wave Wealth Advisors LLC purchased a new stake in Procter & Gamble in the 4th quarter valued at $46,000. Costello Asset Management INC lifted its stake in Procter & Gamble by 2,142.9% during the 3rd quarter. Costello Asset Management INC now owns 314 shares of the company's stock valued at $54,000 after acquiring an additional 300 shares in the last quarter. Mendota Financial Group LLC boosted its holdings in Procter & Gamble by 58.0% during the 4th quarter. Mendota Financial Group LLC now owns 376 shares of the company's stock worth $63,000 after acquiring an additional 138 shares during the last quarter. Finally, Itau Unibanco Holding S.A. raised its holdings in shares of Procter & Gamble by 138.7% in the third quarter. Itau Unibanco Holding S.A. now owns 401 shares of the company's stock valued at $69,000 after purchasing an additional 233 shares during the last quarter. 65.77% of the stock is owned by institutional investors.
Procter & Gamble Price Performance
Shares of NYSE:PG traded up $2.91 on Monday, hitting $168.90. The company's stock had a trading volume of 8,668,582 shares, compared to its average volume of 7,440,821. The Procter & Gamble Company has a 1 year low of $153.52 and a 1 year high of $180.43. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. The company has a market capitalization of $396.05 billion, a PE ratio of 26.90, a PEG ratio of 3.73 and a beta of 0.45. The company has a 50-day simple moving average of $168.34 and a 200 day simple moving average of $169.41.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Wednesday, January 22nd. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.86 by $0.02. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The firm had revenue of $21.88 billion for the quarter, compared to analysts' expectations of $21.66 billion. During the same quarter last year, the company posted $1.84 EPS. The business's quarterly revenue was up 2.1% on a year-over-year basis. Sell-side analysts forecast that The Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Friday, January 24th will be paid a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.38%. The ex-dividend date is Friday, January 24th. Procter & Gamble's dividend payout ratio (DPR) is presently 64.17%.
Analyst Upgrades and Downgrades
Several research firms have commented on PG. Royal Bank of Canada reissued a "sector perform" rating and set a $164.00 target price on shares of Procter & Gamble in a research report on Thursday, January 23rd. Morgan Stanley boosted their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an "overweight" rating in a research report on Monday, October 21st. UBS Group lowered their target price on Procter & Gamble from $196.00 to $189.00 and set a "buy" rating on the stock in a research note on Thursday, January 16th. JPMorgan Chase & Co. reduced their price target on shares of Procter & Gamble from $186.00 to $181.00 and set an "overweight" rating for the company in a research report on Thursday, January 16th. Finally, Stifel Nicolaus boosted their target price on shares of Procter & Gamble from $161.00 to $165.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Eight investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, Procter & Gamble presently has a consensus rating of "Moderate Buy" and a consensus target price of $180.53.
Read Our Latest Report on PG
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the business's stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the transaction, the insider now owns 11,595 shares in the company, valued at approximately $2,002,804.35. The trade was a 52.47 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Marc S. Pritchard sold 90,450 shares of the firm's stock in a transaction dated Thursday, January 23rd. The stock was sold at an average price of $163.84, for a total value of $14,819,328.00. Following the completion of the sale, the insider now directly owns 172,814 shares in the company, valued at $28,313,845.76. The trade was a 34.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 151,097 shares of company stock worth $25,635,076. 0.18% of the stock is currently owned by insiders.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for February 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.